Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Heather, Rasmussen"'
Autor:
April J. Stull, Aedín Cassidy, Luc Djousse, Sarah A. Johnson, Robert Krikorian, Johanna W. Lampe, Kenneth J. Mukamal, David C. Nieman, Kathryn N. Porter Starr, Heather Rasmussen, Eric B. Rimm, Kim S. Stote, Christy Tangney
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
Mounting evidence indicates that blueberry consumption is associated with a variety of health benefits. It has been suggested that regular consumption of blueberries can support and/or protect against cardiovascular disease and function, pre-diabetes
Externí odkaz:
https://doaj.org/article/4299e814ca6c4ae8b855eebdb6f09e4b
Autor:
Cynthia I. Rodriguez, Ali Keshavarzian, Bruce R. Hamaker, Feitong Liu, Genelle R. Lunken, Heather Rasmussen, Hongwei Zhou, Julien Tap, Kelly S. Swanson, Maria Ukhanova, Marion Leclerc, Martin Gotteland, Paola Navarrete, Petia Kovatcheva-Datchary, Wendy J. Dahl, Jennifer B. H. Martiny
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-7 (2023)
Abstract Next generation amplicon sequencing has created a plethora of data from human microbiomes. The accessibility to this scientific data and its corresponding metadata is important for its reuse, to allow for new discoveries, verification of pub
Externí odkaz:
https://doaj.org/article/c3b18ef87820422bb4b84f590f049818
Autor:
Leila B. Giron, Michael J. Peluso, Jianyi Ding, Grace Kenny, Netanel F. Zilberstein, Jane Koshy, Kai Ying Hong, Heather Rasmussen, Gregory E. Miller, Faraz Bishehsari, Robert A. Balk, James N. Moy, Rebecca Hoh, Scott Lu, Aaron R. Goldman, Hsin-Yao Tang, Brandon C. Yee, Ahmed Chenna, John W. Winslow, Christos J. Petropoulos, J. Daniel Kelly, Haimanot Wasse, Jeffrey N. Martin, Qin Liu, Ali Keshavarzian, Alan Landay, Steven G. Deeks, Timothy J. Henrich, Mohamed Abdel-Mohsen
Publikováno v:
JCI Insight, Vol 7, Iss 18 (2022)
Externí odkaz:
https://doaj.org/article/6e5e56aca1ba4618a1ad54b38b692378
Autor:
Ryan C. Lynch, Stefan Alig, Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman, Andrei Shustov, Brian Till, Vikram M. Raghunathan, Yolanda Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jackie Vandermeer, Ashley Gaston, Heather Rasmussen, Avanti Gulhane, Delphine L. Chen, Paul Martin, Edmond Marzbani, Jenna Voutsinas, Ash A. Alizadeh, Ajay K. Gopal
Publikováno v:
HemaSphere, Vol 6, Pp 26-27 (2022)
Externí odkaz:
https://doaj.org/article/1dca62dfced740de83e0d17bd541a259
Autor:
Phillip A. Engen, Antonia Zaferiou, Heather Rasmussen, Ankur Naqib, Stefan J. Green, Louis F. Fogg, Christopher B. Forsyth, Shohreh Raeisi, Bruce Hamaker, Ali Keshavarzian
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Emerging evidence suggests intestinal microbiota as a central contributing factor to the pathogenesis of Relapsing-Remitting-Multiple-Sclerosis (RRMS). This novel RRMS study evaluated the impact of fecal-microbiota-transplantation (FMT) on a broad ar
Externí odkaz:
https://doaj.org/article/f3e30395e2114b7ab610b56fcc97b738
Autor:
Ryan C Lynch, Chaitra S Ujjani, Christina Poh, Edus H Warren, Stephen D Smith, Mazyar Shadman, Brian G. Till, Vikram Raghunathan, Stefan Alig, Ash A Alizadeh, Avanti Gulhane, Delphine Chen, Yolanda Tseng, Hilary Coye, Megan Shelby, Susan Ottemiller, Sarith Keo, Kaitlin Verni, Hongyan Du, Jacquelin Vandermeer, Ashley Gaston, Heather Rasmussen, Paul Martin, Edmond Marzbani, Jenna M Voutsinas, Ajay K Gopal
Publikováno v:
Blood.
Concurrent administration pembrolizumab with chemotherapy in untreated classical Hodgkin lymphoma (CHL) has not previously been studied. To investigate this combination, we conducted a single arm study of concurrent pembrolizumab with AVD (APVD) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81a93ad51981761b7ab0687bc8c79933
https://doi.org/10.1182/blood.2022019254
https://doi.org/10.1182/blood.2022019254
Autor:
Ryan C, Lynch, Christina, Poh, Chaitra S, Ujjani, Edus H, Warren, Stephen D, Smith, Mazyar, Shadman, Karolyn, Morris, Sydney, Lee, Heather, Rasmussen, Susan, Ottemiller, Megan, Shelby, Sarith, Keo, Kaitlin, Verni, David M, Kurtz, Ash A, Alizadeh, Jacob J, Chabon, Gregory J, Hogan, Andre, Schulz, Theodore A, Gooley, Jenna M, Voutsinas, Ajay K, Gopal
Publikováno v:
Blood advances.
The POLARIX trial demonstrated the superiority of polatuzumab vedotin (Pola) over vincristine in the R-CHOP regimen for large B-cell lymphomas, but it is unknown if Pola can be safely incorporated into intensified regimens (eg. DA-EPOCH-R) typically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f1d1fde31fd2e45956a3fdf430e202f
https://pubmed.ncbi.nlm.nih.gov/36521030
https://pubmed.ncbi.nlm.nih.gov/36521030
Autor:
Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A. Gooley, Heather Rasmussen, David G. Coffey, Andrew J. Cowan, Stephen D. Smith, Mazyar Shadman, Edus H. Warren, Edward N. Libby, Alexander L. Greninger, Jonathan R. Fromm, Ajay K. Gopal
Publikováno v:
Blood advances.
Patients with indolent B-cell non-Hodgkin lymphoma (iNHL) generally require treatment but experience normal survival, emphasizing the need for simpler, safer therapies. Proteasome inhibitors target aberrant signaling pathways within iNHL and have man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13593b1de08c3bcc905ba03c71dad87
https://pubmed.ncbi.nlm.nih.gov/36385536
https://pubmed.ncbi.nlm.nih.gov/36385536
Autor:
Hilary Coye, Mazyar Shadman, Karolyn Morris, Christen N. Martino, Andrei R. Shustov, Edus H. Warren, Brian G. Till, Heather Rasmussen, Jenna M. Voutsinas, Sandra L Bhark, Jonathan R. Fromm, Chaitra S. Ujjani, Ryan D. Cassaday, Edward N. Libby, Mary Philip, Andrew J. Cowan, Stephen D. Smith, Sanaz Behnia, Ryan C. Lynch, Ajay K. Gopal
Publikováno v:
The Lancet Haematology. 8:e562-e571
Summary Background Relapsed or refractory classical Hodgkin lymphoma could be treated with multiagent salvage chemotherapy followed by autologous haematopoietic stem-cell transplantation. The aim of this study is to establish the safety and activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::921350ca388e299b28218b46f5a9f08a
https://doi.org/10.1016/s2352-3026(21)00170-8
https://doi.org/10.1016/s2352-3026(21)00170-8
Autor:
Elizabeth F. Krakow, Ryan C. Lynch, Sandra Kanan, Karolyn Morris, Lorinda Soma, Stephen D. Smith, Ryan D. Cassaday, Thomas R. Chauncey, Solomon A. Graf, Sanaz Behnia, Jenna M. Voutsinas, Heather Rasmussen, Qian Vicky Wu, Ajay K. Gopal
Publikováno v:
Clin Lymphoma Myeloma Leuk
Background Histologic transformation to diffuse large B-cell lymphoma (tDLBCL) occurs in a significant proportion of indolent lymphomas. However, few studies of novel agents inform its management, particularly when relapsed after or refractory (R/R)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade92211dfa94b3c30cf2c4c9ec22f0f
https://doi.org/10.1016/j.clml.2020.11.023
https://doi.org/10.1016/j.clml.2020.11.023